undamentalytics Newsletter

McKesson revenue

McKesson's revenue was $403.43bn in fiscal 2026, up 12.4% on the year before. Since fiscal 2010 ($108.70bn) it has grown at a compound 8.5% a year. Over the last twelve months it was $410.98bn.

Revenue history

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

McKesson: revenue history, annual
Fiscal year2010Mar 20102011Mar 20112012Mar 20122013Mar 20132014Mar 20142015Mar 20152016Mar 20162017Mar 20172018Mar 20182019Mar 20192020Mar 20202021Mar 20212022Mar 20222023Mar 20232024Mar 20242025Mar 20252026Mar 2026LTMJun 2026
Revenue108.7112.1122.3122.2137.4179.0190.9198.5208.4214.3231.1238.2264.0276.7309.0359.1403.4411.0
Growth on the year before—+3.1%+9.1%−0.1%+12.4%+30.3%+6.6%+4.0%+4.9%+2.9%+7.8%+3.1%+10.8%+4.8%+11.7%+16.2%+12.4%—
Gross profit5.76.06.46.98.411.411.411.311.211.812.012.113.112.412.813.314.615.0
Gross margin5.2%5.3%5.2%5.6%6.1%6.4%6.0%5.7%5.4%5.5%5.2%5.1%5.0%4.5%4.2%3.7%3.6%3.6%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to March 31, 2026
Segments
Line of business Revenue Share YoY
North American Pharmaceutical $337B 83.7% ▲ 10.6%
Oncology and Multispecialty $48.4B 12.0% ▲ 31.4%
Medical Surgical Solutions $11.5B 2.9% ▲ 1.1%
Prescription Technology Solutions $5.8B 1.4% ▲ 11.3%

From McKesson's 10-K filed May 8, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Distributors: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
McKesson $410.98bn 8.8% 13.1%
Cencora $332.77bn 5.1% 9.4%
Henry Schein $13.60bn 6.5% 2.6%
111, Inc. $1.75bn -12.7% —
Cosmos Health Inc. $73.7m 33.8% 14.8%
Cellyan Biotechnology Co., Ltd $13.4m -33.9% —

Compare with peers

Head to head: COR vs MCKHSIC vs MCKMCK vs YI

More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies

Figures from McKesson's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to McKesson.